Bernstein SocGen Group Reiterates Market Perform Rating on Edwards Lifesciences (EW), 'Bullish Investor Day'

Bernstein SocGen Group analyst Lee Hambright reiterated a Market Perform rating and $72.00 price target on Edwards Lifesciences (NYSE: EW).

The analyst said: "Threading the needle on guidance. Investors wanted to see conservative TAVR guidance, and Edwards guided to 5%-7% TAVR growth for 2025, which checked the box as conservatively below the previous 10%+ LRP (note EW believes TAVR can accelerate to MSD-HSD in 2026 and beyond). At the same time, to maintain EW’s premium multiple, investors needed to believe there’s a path to 10% sales growth for the corporation, and EW guided to 8%-10% sales growth in 2025 and ~10% in 2026 and beyond."

For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.

Shares of Edwards Lifesciences closed at $74.20 yesterday.

You May Also Be Interested In

• GLJ Research Downgrades Fluence Energy Inc. (FLNC) to Hold
• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• Rubrik Inc (RBRK) PT Raised to $120 at Oppenheimer; Sees Another 'Beat and Raise'